August 28, 2025

First Generic GLP-1 for Weight Loss Approved

FDA approves Teva’s generic Saxenda (liraglutide) with adult and adolescent indications and a boxed thyroid tumor warning.

Conexiant

August 28, 2025

Study Identifies Age-Specific Prediabetes Mortality Risk

Researchers found in over 38,000 US adults that prediabetes was linked to higher mortality risk only in those aged 20 to 54 years.

Conexiant

August 27, 2025

FDA Approves LP.8.1 COVID-19 Vaccines

LP.8.1-targeted COVID-19 vaccines for adults 65 and older and higher-risk patients were approved by the US Food and Drug Administration.

Conexiant

August 27, 2025

Fast Walking Tied to Longer Life

As little as 15 minutes per day of fast walking was linked to 19% lower all-cause mortality.

Conexiant

August 26, 2025

Liver Disease May Raise Atrial Fibrillation Risk, Study

"These findings suggest that metabolic dysfunction plays a more significant role in AF occurrence than the direct toxic effects of alcohol."

Conexiant

August 26, 2025

Antithrombotic Therapy Shows Similar Results by Sex

"A patient’s sex should not guide selection of antithrombotic therapies in people with established coronary artery disease."

Conexiant

August 21, 2025

Screen Time May Raise Cardiometabolic Risk in Youth

Researchers link increased screen time in children and adolescents to higher cardiometabolic and cardiovascular risk, with sleep duration identified as a key moderating factor.

Conexiant

August 20, 2025

Combined Therapy Reduces Binge Eating, Weight

Regulation of Cues plus Behavioral Weight Loss outperforms cognitive behavioral therapy for short-term benefits among veterans with binge eating disorder.

Conexiant

August 20, 2025

Frailty Risk High in PRISm Patients

Frailty screening emerges as a critical consideration in PRISm patients as new findings reveal overlapping systemic vulnerabilities with COPD, despite preserved lung function ratio.

Conexiant